Moderna’s Shift to Cancer Company Lifts Stock Up 177%
Reported by New York Times Business · nytimes.com · August 20, 2026
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
What the tape says
What to watch: This report cites a concrete figure (177%) — compare it against the trailing trend before treating one data point as a turning point.
Market reaction today: $MRNA -4.30%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish New York Times Business's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to New York Times Business. Wook of Wall Street is an independent research tool and is not affiliated with New York Times Business. Nothing here is financial advice or a recommendation — research and educational content only.